Skip to main content
SpringerLink
Log in

Increased 10-year cardiovascular disease and mortality risk scores in asymptomatic patients with calcium oxalate urolithiasis

  • Original Paper
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

Both the prevalence of cardiovascular risk factors and event rate are increased in patients with urolithiasis. Screening is recommended to all patients who have high cardiovascular risk. The aim of this study was to document 10-year risk of cardiovascular disease and mortality in asymptomatic patients with urolithiasis. Consecutive 200 patients with calcium oxalate urolithiasis were compared with 200 age- and sex-matched healthy controls. Ten-year cardiovascular disease risk was calculated with the Framingham Risk Score and mortality risk with SCORE risk score. Calcium, oxalate, and citrate excretion were studied as urinary stone risk factors. The results indicate that patients with urolithiasis had higher total cholesterol (p < 0.0001), lower HDL-cholesterol (p < 0.0001), and higher systolic blood pressure (p < 0.0001) and hsCRP (p < 0.0001) compared with controls. Patients with urolithiasis had a higher Framingham Risk Scores [OR 8.36 (95% CI 3.81–18.65), p = 0.0001] and SCORE risk score [OR 3.02 (95% CI 1.30–7.02), p = 0.0006] compared with controls. The Framingham and SCORE risk score were significantly correlated with urinary calcium (p = 0.0001, r = 0.460, and p = 0.005, r = 0.223, respectively) and oxalate excretion (p = 0.0001, r = 0.516, p = 0.001, r = 0.290, respectively). In multiple linear regression analysis, urinary calcium and oxalate excretion, age, sex, total cholesterol, HDL-cholesterol, hsCRP and smoking were the independent predictors of 10-year cardiovascular disease risk and urinary calcium and oxalate excretion, age, sex, total cholesterol, fasting blood glucose for 10-year cardiovascular mortality. In conclusion, patients with calcium oxalate urolithiasis carry high risk of cardiovascular disease and mortality. All patients should be screened at the initial diagnosis of urolithiasis for the risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63(5):1817–1823

    Article  PubMed  Google Scholar 

  2. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O’Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y, American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2009) Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119(3):e21–e181

    Article  PubMed  Google Scholar 

  3. Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455–462

    Article  PubMed  CAS  Google Scholar 

  4. Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68:1230–1235

    Article  PubMed  Google Scholar 

  5. Cirillo M, Laurenzi M (1988) Elevated blood pressure and positive history of kidney stones: results from a population-based study. J Hypertens Suppl 6(4):S485–S486

    PubMed  CAS  Google Scholar 

  6. Traxer O, Safar H, Daudon M, Haymann JP (2006) Metabolic syndrome, obesity and urolithiasis. Prog Urol 16(4):418–420

    PubMed  Google Scholar 

  7. Rule AD, Roger VL, Melton LJ 3rd, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC (2010) Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 21(10):1641–1644

    Article  PubMed  Google Scholar 

  8. WritingCommittee Members, Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK (2010) 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 122(25):e584–e636

    Article  PubMed  Google Scholar 

  9. Kappagoda CT, Amsterdam EA (2009) Assessment of risk for developing coronary heart disease in asymptomatic individuals. J Cardiopulm Rehabil Prev 29(4):207–219

    PubMed  Google Scholar 

  10. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, SCORE project group (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24(11):987–1003

    Article  PubMed  CAS  Google Scholar 

  11. Raynal G, Achkar K, El Samad R, Kikassa JC, Jorest R (2008) Cardiovascular risk associated with urolithiasis. Prog Urol 18(5):288–291

    Article  PubMed  CAS  Google Scholar 

  12. Domingos F, Serra A (2011) Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant 26(3):864–868

    Google Scholar 

  13. Zimmerer T, Weiss C, Hammes HP, Braun C, Hesse A, Alken P, Knoll T (2009) Evaluation of urolithiasis: a link between stone formation and diabetes mellitus? Urol Int 82(3):350–355

    Article  PubMed  CAS  Google Scholar 

  14. Obligado SH, Goldfarb DS (2008) The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21(3):257–264

    Article  PubMed  CAS  Google Scholar 

  15. West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis 51(5):741–747

    Article  PubMed  Google Scholar 

  16. Mossetti G, Rendina D, De Filippo G, Benvenuto D, Vivona CL, Zampa G, Ferraro P, Strazzullo P (2008) Metabolic syndrome and nephrolithiasis: can we hypotize a common background? Clin Cases Mineral Bone Metab 5(2):114–117

    Google Scholar 

  17. Daudon M, Doré JC, Jungers P, Lacour B (2004) Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res 32(3):241–247

    Article  PubMed  Google Scholar 

  18. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356–359

    Article  PubMed  Google Scholar 

  19. Ford ES (2004) Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am 33(2):333–350

    Article  PubMed  Google Scholar 

  20. Costa EC, de Sá JC, Soares EM, Lemos TM, Maranhão TM, Azevedo GD (2010) Evaluation of cardiovascular risk by the LAP index in non-obese patients with polycystic ovary syndrome. Arq Bras Endocrinol Metabol 54(7):630–635

    Article  PubMed  Google Scholar 

  21. Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363(14):1341–1350

    Article  PubMed  CAS  Google Scholar 

  22. Ljunghall S, Hedstrand H (1976) Renal stones and coronary heart disease. Acta Med Scand 199(6):481–485

    Article  PubMed  CAS  Google Scholar 

  23. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868–874

    Article  PubMed  CAS  Google Scholar 

  24. Tsao KC, Wu TL, Chang PY, Sun CF, Wu LL, Wu JT (2007) Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal 21(6):426–431

    Article  PubMed  Google Scholar 

  25. Cupisti A, Meola M, D’Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G (2007) Insulin resistance and low urinary citrate excretion in calcium stone formers. Biomed Pharmacother 61(1):86–90

    Article  PubMed  CAS  Google Scholar 

  26. Eisner BH, Eisenberg ML, Stoller ML (2010) Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis. Urology 75(6):1289–1293

    Article  PubMed  Google Scholar 

  27. Chou YH, Su CM, Li CC, Liu CC, Liu ME, Wu WJ, Juan YS (2010) Difference in urinary stone components between obese and non-obese patients. Urol Res (Epub ahead of print)

  28. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun M (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363(23):2211–2219

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

No grants or fellowship supported the writing of the paper.

Conflict of interest

The authors have nothing to disclose.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Section of Endocrinology and Metabolism, Yeditepe University Medical Faculty, Devlet Yolu Ankara Cad. No: 102–104, Kozyatagi, Istanbul, 34752, Turkey

    Hasan Aydin

  2. Department of Urology, Yeditepe University Medical Faculty, Istanbul, Turkey

    Faruk Yencilek, Ismet Bilger Erihan & Kemal Sarica

  3. Section of Diet and Nutrition, Yeditepe University Hospital, Istanbul, Turkey

    Binnur Okan

Authors
  1. Hasan Aydin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Faruk Yencilek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ismet Bilger Erihan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Binnur Okan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kemal Sarica
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hasan Aydin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aydin, H., Yencilek, F., Erihan, I.B. et al. Increased 10-year cardiovascular disease and mortality risk scores in asymptomatic patients with calcium oxalate urolithiasis. Urol Res 39, 451–458 (2011). https://doi.org/10.1007/s00240-011-0383-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-011-0383-9

Keywords

Search

Navigation